These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7398746)
1. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers. Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746 [No Abstract] [Full Text] [Related]
2. Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit. Hunt RJ; Miller KW Drug Metab Dispos; 1978; 6(1):75-81. PubMed ID: 23277 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs. Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140 [TBL] [Abstract][Full Text] [Related]
4. Microassay for primidone and its metabolites phenylethylmalondiamide, phenobarbital and p-hydroxyphenobarbital in human serum, saliva, breast milk and tissues by gas chromatography--mass spectrometry using selected ion monitoring. Nau H; Jesdinsky D; Wittfoht W J Chromatogr; 1980 Apr; 182(1):71-9. PubMed ID: 7380904 [TBL] [Abstract][Full Text] [Related]
5. Phenylethylmalonamide (PEMA). An important metabolite of primidone. Baumel IP; Gallagher BB; Mattson RH Arch Neurol; 1972 Jul; 27(1):34-41. PubMed ID: 4626105 [No Abstract] [Full Text] [Related]
6. Interactions between primidone, carbamazepine, and nicotinamide. Bourgeois BF; Dodson WE; Ferrendelli JA Neurology; 1982 Oct; 32(10):1122-26. PubMed ID: 6214728 [TBL] [Abstract][Full Text] [Related]
7. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. Nau H; Rating D; Koch S; Häuser I; Helge H J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient. Porro MG; Kupferberg HJ; Porter RJ; Theodore WH; Newmark ME Br J Clin Pharmacol; 1982 Aug; 14(2):294-7. PubMed ID: 7104185 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration. Pisani F; Richens A Clin Pharmacokinet; 1983; 8(3):272-6. PubMed ID: 6851372 [TBL] [Abstract][Full Text] [Related]
10. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs. Streete JM; Berry DJ; Pettit LI; Newbery JE Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778 [TBL] [Abstract][Full Text] [Related]
11. The disposition of primidone in elderly patients. Martines C; Gatti G; Sasso E; Calzetti S; Perucca E Br J Clin Pharmacol; 1990 Oct; 30(4):607-11. PubMed ID: 2291873 [TBL] [Abstract][Full Text] [Related]
12. Studies on the intracerebral metabolism of anticonvulsant drugs--I. Perfusion of primidone through the isolated brain of the rat. Höller M; Penin H Biochem Pharmacol; 1984 Jun; 33(11):1753-6. PubMed ID: 6732842 [TBL] [Abstract][Full Text] [Related]
13. Effects of encapsulation of primidone on its oxidative metabolism in rats. Ferranti V; Chabenat C; Marchais H; Ménager S; Hue H; Orecchioni AM; Lafont O Drug Metabol Drug Interact; 2001; 18(3-4):191-208. PubMed ID: 11791884 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of primidone and its active metabolites in the dog. Frey HH; Göbel W; Löscher W Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):14-30. PubMed ID: 543743 [TBL] [Abstract][Full Text] [Related]
15. Single-dose kinetics of primidone in human subjects: effect of phenytoin on formation and elimination of active metabolites of primidone, phenobarbital and phenylethylmalonamide. Sato J; Sekizawa Y; Yoshida A; Owada E; Sakuta N; Yoshihara M; Goto T; Kobayashi Y; Ito K J Pharmacobiodyn; 1992 Sep; 15(9):467-72. PubMed ID: 1287181 [TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of primidone and its metabolites, phenylethylmalonamide and phenobarbital, in the dog. Yeary RA Am J Vet Res; 1980 Oct; 41(10):1643-5. PubMed ID: 7224290 [TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Frey HH; Löscher W; Reiche R; Schultz D Pharmacology; 1984; 28(6):329-35. PubMed ID: 6728906 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs. Cunningham JG; Haidukewych D; Jensen HA J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121 [TBL] [Abstract][Full Text] [Related]
19. Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women. Rating D; Nau H; Jäger-Roman E; Göpfert-Geyer I; Koch S; Beck-Mannagetta G; Schmidt D; Helge H Acta Paediatr Scand; 1982 Mar; 71(2):301-11. PubMed ID: 7136638 [TBL] [Abstract][Full Text] [Related]
20. Epileptiform seizures in domestic fowl. VIII. Anticonvulsant activity of primidone and its metabolites, phenobarbital and phenylethylmalonamide. Johnson DD; Davis HL; Crawford RD Can J Physiol Pharmacol; 1978 Aug; 56(4):630-3. PubMed ID: 688087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]